Skip to main content

Animations

MJFF Publications

5241 - 5250 of 8823 Results
Title
Year
  • Year
  • 2025
  • 2024
  • 2024
  • 2025
  • 2025
  • 2025
  • 2024
  • 2025
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Intestinal biomarkers, microbiota composition, and genetic predisposition to inflammatory bowel disease as predictors of Parkinson's disease manifestation
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/1877718x251328567
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Exploring the Potential Imaging Biomarkers for Parkinson’s Disease Using Machine Learning Approach
    Journal Name: Bioengineering
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/bioengineering12010011
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Replication and reliability of Parkinson's disease clinical subtypes
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107016
    Citation Count: 2
  • Summary Details
    OPEN
    Title: The Exon-Based Transcriptomic Analysis of Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom15030440
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Virtual Compound Screening for Discovery of Dopamine D1 Receptor Biased Allosteric Modulators
    Journal Name: Journal of Chemical Information and Modeling
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acs.jcim.5c00972
    Citation Count: 1
  • Summary Details
    OPEN
    Title: The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-025-00896-2
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Dopamine neuron activity encodes the length of upcoming contralateral movement sequences
    Journal Name: Current Biology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1016/j.cub.2024.01.067
    Citation Count: 16
  • Summary Details
    OPEN
    Title: Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study
    Journal Name: eBioMedicine
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ebiom.2025.105567
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00395-8
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adn6016
    Citation Count: 29
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.